Antonin Tutter, Dennis Buckley, Andrei A. Golosov, Xiaolei Ma, Wei Shu, Daniel J. J. McKay, Veronique Darsigny, Dustin Dovala, Rohan Beckwith, Jonathan Solomon, Pasupuleti Rao, Lei Xu, Aleem Fazal, Andreas Lingel, Charles Wartchow, Jennifer S. Cobb, Amanda Hachey, Jennifer Tullai, Gregory A. Michaud
{"title":"A small-molecule VHL molecular glue degrader for cysteine dioxygenase 1","authors":"Antonin Tutter, Dennis Buckley, Andrei A. Golosov, Xiaolei Ma, Wei Shu, Daniel J. J. McKay, Veronique Darsigny, Dustin Dovala, Rohan Beckwith, Jonathan Solomon, Pasupuleti Rao, Lei Xu, Aleem Fazal, Andreas Lingel, Charles Wartchow, Jennifer S. Cobb, Amanda Hachey, Jennifer Tullai, Gregory A. Michaud","doi":"10.1038/s41589-025-01936-x","DOIUrl":null,"url":null,"abstract":"<p>The von Hippel–Lindau tumor suppressor gene product (pVHL) is an E3 ligase substrate receptor that binds proline-hydroxylated hypoxia-inducible factor HIF1α, leading to its ubiquitin-dependent degradation. By using protein arrays, we identified a small molecule that binds the HIF1α-binding pocket on pVHL and functions as a molecular glue degrader of the neosubstrate cysteine dioxygenase (CDO1) by recruiting it into the VHL–Cullin–RING E3 ligase complex and leading to its selective degradation. The CDO1-binding region involved in VHL recruitment was characterized through a combination of mutagenesis and protein–protein docking coupled with molecular-dynamics-based solvation analysis. The X-ray structure of the ternary complexes of VHL, CDO1 and degrader molecules confirms the binding region prediction and provides atomic insights into key molecular glue interactions.</p><figure></figure>","PeriodicalId":18832,"journal":{"name":"Nature chemical biology","volume":"25 1","pages":""},"PeriodicalIF":13.7000,"publicationDate":"2025-06-24","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Nature chemical biology","FirstCategoryId":"99","ListUrlMain":"https://doi.org/10.1038/s41589-025-01936-x","RegionNum":1,"RegionCategory":"生物学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"BIOCHEMISTRY & MOLECULAR BIOLOGY","Score":null,"Total":0}
引用次数: 0
Abstract
The von Hippel–Lindau tumor suppressor gene product (pVHL) is an E3 ligase substrate receptor that binds proline-hydroxylated hypoxia-inducible factor HIF1α, leading to its ubiquitin-dependent degradation. By using protein arrays, we identified a small molecule that binds the HIF1α-binding pocket on pVHL and functions as a molecular glue degrader of the neosubstrate cysteine dioxygenase (CDO1) by recruiting it into the VHL–Cullin–RING E3 ligase complex and leading to its selective degradation. The CDO1-binding region involved in VHL recruitment was characterized through a combination of mutagenesis and protein–protein docking coupled with molecular-dynamics-based solvation analysis. The X-ray structure of the ternary complexes of VHL, CDO1 and degrader molecules confirms the binding region prediction and provides atomic insights into key molecular glue interactions.
von Hippel-Lindau肿瘤抑制基因产物(pVHL)是E3连接酶底物受体,结合脯氨酸羟基化缺氧诱导因子HIF1α,导致其泛素依赖性降解。通过蛋白质阵列,我们发现了一个结合pVHL上hif1 α-结合袋的小分子,并通过将其招募到VHL-Cullin-RING E3连接酶复合体中,并导致其选择性降解,从而作为新底物半胱氨酸双加氧酶(CDO1)的分子胶降解剂。通过诱变、蛋白-蛋白对接以及基于分子动力学的溶剂化分析,对参与VHL募集的cdo1结合区进行了表征。VHL, CDO1和降解分子的三元配合物的x射线结构证实了结合区预测,并提供了关键分子胶相互作用的原子见解。
期刊介绍:
Nature Chemical Biology stands as an esteemed international monthly journal, offering a prominent platform for the chemical biology community to showcase top-tier original research and commentary. Operating at the crossroads of chemistry, biology, and related disciplines, chemical biology utilizes scientific ideas and approaches to comprehend and manipulate biological systems with molecular precision.
The journal embraces contributions from the growing community of chemical biologists, encompassing insights from chemists applying principles and tools to biological inquiries and biologists striving to comprehend and control molecular-level biological processes. We prioritize studies unveiling significant conceptual or practical advancements in areas where chemistry and biology intersect, emphasizing basic research, especially those reporting novel chemical or biological tools and offering profound molecular-level insights into underlying biological mechanisms.
Nature Chemical Biology also welcomes manuscripts describing applied molecular studies at the chemistry-biology interface due to the broad utility of chemical biology approaches in manipulating or engineering biological systems. Irrespective of scientific focus, we actively seek submissions that creatively blend chemistry and biology, particularly those providing substantial conceptual or methodological breakthroughs with the potential to open innovative research avenues. The journal maintains a robust and impartial review process, emphasizing thorough chemical and biological characterization.